1. Home
  2. DSY vs CUE Comparison

DSY vs CUE Comparison

Compare DSY & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

HOLD

Current Price

$0.29

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.42

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSY
CUE
Founded
2020
2014
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
49.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
DSY
CUE
Price
$0.29
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
136.8K
249.2K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
120.37
N/A
EPS
0.01
N/A
Revenue
$7,323,356.00
$7,100,000.00
Revenue This Year
N/A
$36.58
Revenue Next Year
N/A
$32.10
P/E Ratio
$27.43
N/A
Revenue Growth
16.37
N/A
52 Week Low
$0.32
$0.47
52 Week High
$7.33
$1.75

Technical Indicators

Market Signals
Indicator
DSY
CUE
Relative Strength Index (RSI) 16.10 22.60
Support Level $0.24 $0.47
Resistance Level $0.36 $0.51
Average True Range (ATR) 0.03 0.05
MACD -0.00 -0.01
Stochastic Oscillator 23.54 0.00

Price Performance

Historical Comparison
DSY
CUE

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: